The Chemokine CXCL13 (BCA-1) Inhibits FGF-2 Effects on Endothelial Cells
- 1 November 2001
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 289 (1) , 19-24
- https://doi.org/10.1006/bbrc.2001.5924
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The Biology of Chemokines and their ReceptorsAnnual Review of Immunology, 2000
- Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor Induce Expression of CXCR4 on Human Endothelial CellsThe American Journal of Pathology, 1999
- Platelet Factor 4 Modulates Fibroblast Growth Factor 2 (FGF-2) Activity and Inhibits FGF-2 DimerizationBlood, 1998
- Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growthNature Medicine, 1997
- gro-beta, a -C-X-C- chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice.The Journal of Experimental Medicine, 1995
- The Functional Role of the ELR Motif in CXC Chemokine-mediated AngiogenesisJournal of Biological Chemistry, 1995
- The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation.The Journal of Experimental Medicine, 1995
- Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo.The Journal of Experimental Medicine, 1995
- Platelet Factor-4 Inhibits the Mitogenic Activity of VEGF121 and VEGF165 Using Several Concurrent MechanismsJournal of Biological Chemistry, 1995
- Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression.The Journal of cell biology, 1994